HEALTH AND HUMAN SERVICES, DEPARTMENT OF has floated a tender for Evaluation and Testing Services (Ets) for Vaccines and other Biologics for Infectious Diseases. The project location is USA and the tender is closing on 22 Apr 2024. The tender notice number is 75N904, while the TOT Ref Number is 99857016. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.

Expired Tender

Procurement Summary

Country : USA

Summary : Evaluation and Testing Services (Ets) for Vaccines and other Biologics for Infectious Diseases

Deadline : 22 Apr 2024

Other Information

Notice Type : Tender

TOT Ref.No.: 99857016

Document Ref. No. : 75N904

Competition : ICB

Financier : Self Financed

Purchaser Ownership : Public

Tender Value : Refer Document

Purchaser's Detail

Purchaser : HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Contracting Office Address : BETHESDA, MD 20892
Primary Point of Contact : Sharee Richardson
sharee.richardson@nih.gov
Phone Number 240-669-5116

USA
Email :sharee.richardson@nih.gov

Tender Details

Description

DESCRIPTION



The purpose of the solicitation will be to recompete a NIAID resource entitled “EVALUATION AND TESTING SERVICES (ETSV) FOR VACCINES AND OTHER BIOLOGICS FOR INFECTIOUS DISEASES” that provides a suite of preclinical, non-clinical, and clinical testing services for vaccines and other biologic products. While the overall suite of testing services is comprehensive, the intent is to provide individual services on a case-by-case basis for a diverse collection of vaccine and biological product candidates, rather than carry a single product candidate through an entire preclinical development pathway. These services are intended to help a wide variety of investigators in a broad number of scientific areas obtain critical data needed to acquire additional funding, gain prospective partnerships (either for further development or to support Phase I/II/III clinical trials), fulfill regulatory requirements, and complete studies needed to apply for an IND and enter Phase I/II/III clinical trials.



These testing capabilities may also support vaccines or other biological products that are intended to interrupt or block pathogen transmission (such as vector-borne diseases) or for use in animals that constitute a disease reservoir for, or other disease threat from, a pathogen that has public health significance. Support for efforts associated with zoonotic diseases may be considered on a case-by-case basis dependent on adequate justification for public health considerations.
Active Contract Opportunity Notice ID 75N904 Related Notice Department/Ind. Agency HEALTH AND HUMAN SERVICES, DEPARTMENT OF Sub-tier NATIONAL INSTITUTES OF HEALTH Office NIH NIAID DEA OA OFC ACQUISITIONS
General Information
Contract Opportunity Type: Sources Sought (Original)
All Dates/Times are: (UTC-04:00) EASTERN STANDARD TIME, NEW YORK, USA
Original Published Date: Apr 08, 2024 03:55 pm EDT
Original Response Date: Apr 22, 2024 12:00 pm EDT
Inactive Policy: 15 days after response date
Original Inactive Date: May 07, 2024
Initiative: None

Classification
Original Set Aside:
Product Service Code:
NAICS Code: 541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Place of Performance:

Documents

 Tender Notice

Sources-Sought-Notice.pdf